Arbutus Biopharma Corporation (ABUS) dipped -6.43% or -0.25 to $3.64. It is near to 71429 shares traded, which is 35.91% compare to the average total volume 198921. The market cap of ABUS is $201.94 million. The year to date change is -9.18%. The 52 week price range is from $3.2 to $12.6. Price of ABUS have changed 4.01% during last week. It have changed 4.29% over last month, -12.19% over last 3 months, -59.69% over last 6 months and -26.60% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ABUS is 3.98. It is 9.34% above current price. The 200-day Moving Averages for ABUS is 6.62. It is 81.87% above current price. The 52-week High is 12.6. It is 246.15% from the current price. The 52-week Low is 3.2. It is -12.09% from current price.
There are some statistics of ABUS. It is has market cap $201.94 million. The share outstanding is 55.48 million. The average volume is 198921. The percent of top 15 Institution holding is 51.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ABUS is -64.55%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ABUS is -34.42%.